Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome
- PMID: 12649336
Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome
Abstract
B cell activating factor (BAFF) is known to be a powerful regulator of B-cell differentiation and proliferation. The aim of this study was to assess the incidence of apoptosis among BAFF-expressing cells in Sjögren's syndrome (SS) salivary gland tissue. We performed double stainings of BAFF together with one of the markers, CD21, CD68, CD40, Fas, Bcl-2 or Bax, and monitored apoptosis among BAFF expressing cells by using the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-digoxigenin nick-end labeling method. A significantly lower level of apoptosis among the BAFF-expressing cells was detected in salivary glands from patients with SS compared with controls (p = 0.03). Furthermore, no difference in the coexpression of Fas or CD40 together with BAFF was detected between patients and controls. Coexpression of the pro apoptotic molecule Bax together with BAFF was nonsignificantly decreased in patients with SS compared with controls. Our results suggest that a reduced level of apoptosis among BAFF-expressing cells might lead to longer-existing BAFF expression within these cells and thereby maintain signaling for tissue-infiltrating B cells to proliferate and mature.
Similar articles
-
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.Arthritis Res Ther. 2006;8(2):R51. doi: 10.1186/ar1912. Epub 2006 Feb 28. Arthritis Res Ther. 2006. PMID: 16507175 Free PMC article.
-
Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.J Pathol. 2004 Apr;202(4):496-502. doi: 10.1002/path.1533. J Pathol. 2004. PMID: 15095277
-
Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.Arthritis Rheum. 2007 Apr;56(4):1134-44. doi: 10.1002/art.22458. Arthritis Rheum. 2007. PMID: 17393395
-
The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.Scand J Immunol. 2005 Nov;62(5):421-8. doi: 10.1111/j.1365-3083.2005.01688.x. Scand J Immunol. 2005. PMID: 16305638 Review.
-
Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.Transl Res. 2006 Dec;148(6):281-8. doi: 10.1016/j.trsl.2006.07.003. Transl Res. 2006. PMID: 17162248 Review.
Cited by
-
Chronic Inflammation: A Common Promoter in Tertiary Lymphoid Organ Neogenesis.Front Immunol. 2019 Dec 18;10:2938. doi: 10.3389/fimmu.2019.02938. eCollection 2019. Front Immunol. 2019. PMID: 31921189 Free PMC article. Review.
-
Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.Ocul Surf. 2009 Jan;7(1):11-27. doi: 10.1016/s1542-0124(12)70289-6. Ocul Surf. 2009. PMID: 19214349 Free PMC article. Review.
-
B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation.J Immunol. 2008 Jun 1;180(11):7394-403. doi: 10.4049/jimmunol.180.11.7394. J Immunol. 2008. PMID: 18490739 Free PMC article.
-
Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.Int J Rheumatol. 2009;2009:424935. doi: 10.1155/2009/424935. Epub 2010 Jan 28. Int J Rheumatol. 2009. PMID: 20148068 Free PMC article.
-
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.Arthritis Res Ther. 2006;8(2):R51. doi: 10.1186/ar1912. Epub 2006 Feb 28. Arthritis Res Ther. 2006. PMID: 16507175 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous